ROSZET
These highlights do not include all the information needed to use ROSZET safely and effectively. See full prescribing information for ROSZET. ROSZET (rosuvastatin and ezetimibe) tablets, for oral useInitial U.S. Approval: 2021
1653b3c4-2b2a-408b-918a-c687918c6265
HUMAN PRESCRIPTION DRUG LABEL
Sep 15, 2021
Althera Pharmaceuticals LLC
DUNS: 116817996
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
(rosuvastatin and ezetimibe)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
rosuvastatin and ezetimibe
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
(rosuvastatin and ezetimibe)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (18)
(rosuvastatin and ezetimibe)
Product Details
FDA regulatory identification and product classification information